Diogene’s Genetic Diagnosis product range

Genetic Testing service

  • 1 Tumoclean™ cancer genetic testing service
  • 2 HealthyGuide™ DTC genetic testing service
  • 3 MICROBI™ gut microbiome testing service

Learn more

CancerᆞDisease
diagnostic reagent

  • 1 Various types of cancer gene diagnostic reagents
  • 2 Infectious disease diagnostic reagents

Learn more

COVID-19
RT-LAMP Kit

  • 1DLP™Q COVID19 RT-LAMP kit(real-time) is in vitro diagnostic kit for qualitative analysis to diagnose severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection within 30 min.

Learn more

Animal disease
diagnostic reagent

  • 1 Pet disease diagnostic reagents
  • 2 Livestock animal disease diagnostic reagents

Learn more

Diogene’s core technology

1

Diagnoses multiple disease genes at once through simultaneous multi-real-time diagnosis.

2

Accurately detects and diagnoses single-nucleotide polymorphisms or even trace mutations.

3

Perfect control of false positive and false positive signals.

4

Any genetic diagnosis or disease diagnosis is performed within 30 minutes.

Simultaneous multiple-time analysis technology utilizing multiple miRNA biomarkers

Through genomic-based multi-diagnosis testing technology and Diogene's simultaneous multi-time analysis source technology (DLP™), we provide services to diagnose various cancers and diseases in earlier stage.

We have genomic therapeutic candidates for colorectal cancer, pancreatic cancer, cervical cancer, breast cancer, and Alzheimer's disease.Through this, we have completed the foundation for growth as a comprehensive healthcare manufacturing company that can manufacture customized genomic therapeutics and customized health functional foods.

    DLP™C MPCR

    Multipolyticase chain reaction technology

    Check for 40 gene mutations in one kit

    Patent in USA, China & Japan

    miRNA biomarker

    miRNA biomarker

    Technology to diagnose cancer early with high accuracy using multiple miRNA biomarkers and analytical algorithms optimized for cancer diagnosis.

    DLP™Q MANSA

    Nucleic acid amplification technology with multi-amplification dual signal amplification

    A technology that maximizes sensitivity by fusing Multiplex and real-time PCR, and analyzes the increase in amplification products in real time

    Patent in process for China, Japan & Europe

    Genomic Therapy Candidates

    Genomic Therapy Candidates

    Cervical cancer, breast cancer, colorectal cancer, pancreatic cancer, Alzheimer's

    DLP™Q RAPID

    Ultra-fast, real-time gene amplification technology

    Technology that maximizes the advantages of real-time PCR, enabling real-time analysis results to be verified, allowing all samples to be tested in less than 30 minutes.

    R&D partnership

    We are able to develop customized products that are optimized for our partner's development requirements.

    By using Diogene’s source patented technology DLP and application technology, we are able to develop products optimized for our partner’s development requirement including joint development, technology transmission, OEM of customized diagnostic products.

    Joint development
    Transfer of technology
    OEM

    Business network

    We provide cancer and disease genetic testing services to various medical institutions, BT, IT companies, and government
    agencies at home and abroad, and are also conducting cooperative projects such as joint research on diagnostic reagents.